Takara Bio Inc
TSE:4974

Watchlist Manager
Takara Bio Inc Logo
Takara Bio Inc
TSE:4974
Watchlist
Price: 991 JPY -0.1% Market Closed
Market Cap: 119.3B JPY
Have any thoughts about
Takara Bio Inc?
Write Note

Takara Bio Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Takara Bio Inc
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Takara Bio Inc
TSE:4974
Cash from Investing Activities
-ÂĄ2.6B
CAGR 3-Years
40%
CAGR 5-Years
15%
CAGR 10-Years
9%
GNI Group Ltd
TSE:2160
Cash from Investing Activities
-ÂĄ9.6B
CAGR 3-Years
-333%
CAGR 5-Years
-52%
CAGR 10-Years
-45%
PeptiDream Inc
TSE:4587
Cash from Investing Activities
ÂĄ9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharma Foods International Co Ltd
TSE:2929
Cash from Investing Activities
-ÂĄ1.4B
CAGR 3-Years
-47%
CAGR 5-Years
-36%
CAGR 10-Years
-23%
S
StemRIM Inc
TSE:4599
Cash from Investing Activities
-ÂĄ4.8m
CAGR 3-Years
63%
CAGR 5-Years
6%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Cash from Investing Activities
-ÂĄ35m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Takara Bio Inc
Glance View

Market Cap
119.3B JPY
Industry
Biotechnology

Takara Bio, Inc. engages in development and marketing of genetic engineering technologies. The company is headquartered in Kusatsu-Shi, Shiga-Ken and currently employs 1,539 full-time employees. The company went IPO on 2004-12-07. The firm operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.

Intrinsic Value
1 040.99 JPY
Undervaluation 5%
Intrinsic Value
Price

See Also

What is Takara Bio Inc's Cash from Investing Activities?
Cash from Investing Activities
-2.6B JPY

Based on the financial report for Sep 30, 2024, Takara Bio Inc's Cash from Investing Activities amounts to -2.6B JPY.

What is Takara Bio Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
9%

Over the last year, the Cash from Investing Activities growth was 74%. The average annual Cash from Investing Activities growth rates for Takara Bio Inc have been 40% over the past three years , 15% over the past five years , and 9% over the past ten years .

Back to Top